Sprussel A, Suzuki T, Miyata N, Astrahantseff K, Szymansky A, Toedling J
J Clin Med. 2024; 13(20).
PMID: 39458030
PMC: 11508765.
DOI: 10.3390/jcm13206081.
Reyser T, Paloque L, Augereau J, Di Stefano L, Benoit-Vical F
Malar J. 2024; 23(1):44.
PMID: 38347549
PMC: 10863139.
DOI: 10.1186/s12936-024-04855-9.
Mao F, Shi Y
Adv Exp Med Biol. 2023; 1433:15-49.
PMID: 37751134
DOI: 10.1007/978-3-031-38176-8_2.
Padalino G, Celatka C, Rienhoff Jr H, Kalin J, Cole P, Lassalle D
Wellcome Open Res. 2023; 8:146.
PMID: 37520936
PMC: 10375057.
DOI: 10.12688/wellcomeopenres.18826.1.
Noce B, Di Bello E, Fioravanti R, Mai A
Front Pharmacol. 2023; 14:1120911.
PMID: 36817147
PMC: 9932783.
DOI: 10.3389/fphar.2023.1120911.
Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates.
Ota Y, Itoh Y, Kurohara T, Singh R, Elboray E, Hu C
ACS Med Chem Lett. 2022; 13(10):1568-1573.
PMID: 36262394
PMC: 9575174.
DOI: 10.1021/acsmedchemlett.2c00126.
Design, synthesis, and structure activity relationship analysis of new betulinic acid derivatives as potent HIV inhibitors.
Zhao Y, Chen C, Morris-Natschke S, Lee K
Eur J Med Chem. 2021; 215:113287.
PMID: 33639343
PMC: 8176629.
DOI: 10.1016/j.ejmech.2021.113287.
Epigenetic regulation of cancer stem cell formation and maintenance.
French R, Pauklin S
Int J Cancer. 2020; 148(12):2884-2897.
PMID: 33197277
PMC: 8246550.
DOI: 10.1002/ijc.33398.
Synthesis of artificial substrate based on inhibitor for detecting LSD1 activity.
Ohta Y, Kawaguchi M, Ieda N, Nakagawa H
J Clin Biochem Nutr. 2020; 67(2):153-158.
PMID: 33041512
PMC: 7533851.
DOI: 10.3164/jcbn.20-9.
Selective lysine-specific demethylase 1 inhibitor, NCL1, could cause testicular toxicity via the regulation of apoptosis.
Nozaki S, Naiki T, Naiki-Ito A, Iwatsuki S, Takeda T, Etani T
Andrology. 2020; 8(6):1895-1906.
PMID: 32598553
PMC: 7689788.
DOI: 10.1111/andr.12846.
Genome-wide ChIP-seq data with a transcriptome analysis reveals the groups of genes regulated by histone demethylase LSD1 inhibition in esophageal squamous cell carcinoma cells.
Hoshino I, Takahashi M, Akutsu Y, Murakami K, Matsumoto Y, Suito H
Oncol Lett. 2019; 18(1):872-881.
PMID: 31289565
PMC: 6539443.
DOI: 10.3892/ol.2019.10350.
Identification of ryuvidine as a KDM5A inhibitor.
Mitsui E, Yoshida S, Shinoda Y, Matsumori Y, Tsujii H, Tsuchida M
Sci Rep. 2019; 9(1):9952.
PMID: 31289306
PMC: 6616564.
DOI: 10.1038/s41598-019-46346-x.
NCL1, A Highly Selective Lysine-Specific Demethylase 1 Inhibitor, Suppresses Castration-Resistant Prostate Cancer Growth via Regulation of Apoptosis and Autophagy.
Etani T, Naiki T, Naiki-Ito A, Suzuki T, Iida K, Nozaki S
J Clin Med. 2019; 8(4).
PMID: 30935141
PMC: 6517972.
DOI: 10.3390/jcm8040442.
Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells.
Wobser M, Weber A, Glunz A, Tauch S, Seitz K, Butelmann T
J Hematol Oncol. 2019; 12(1):30.
PMID: 30885250
PMC: 6423872.
DOI: 10.1186/s13045-019-0719-4.
Pharmacological Inhibition of LSD1 for Cancer Treatment.
Yang G, Lei P, Wong S, Ma D, Leung C
Molecules. 2018; 23(12).
PMID: 30518104
PMC: 6320820.
DOI: 10.3390/molecules23123194.
Epigenetic regulation of prostate cancer: the theories and the clinical implications.
Liao Y, Xu K
Asian J Androl. 2018; 21(3):279-290.
PMID: 30084432
PMC: 6498736.
DOI: 10.4103/aja.aja_53_18.
Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures.
Ota Y, Kakizawa T, Itoh Y, Suzuki T
Molecules. 2018; 23(5).
PMID: 29734782
PMC: 6099693.
DOI: 10.3390/molecules23051099.
Inhibitors of Protein Methyltransferases and Demethylases.
Umit Kaniskan H, Martini M, Jin J
Chem Rev. 2017; 118(3):989-1068.
PMID: 28338320
PMC: 5610952.
DOI: 10.1021/acs.chemrev.6b00801.
Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases.
Niwa H, Umehara T
Epigenetics. 2017; 12(5):340-352.
PMID: 28277979
PMC: 5453194.
DOI: 10.1080/15592294.2017.1290032.
A chemical probe toolbox for dissecting the cancer epigenome.
Shortt J, Ott C, Johnstone R, Bradner J
Nat Rev Cancer. 2017; 17(3):160-183.
PMID: 28228643
DOI: 10.1038/nrc.2016.148.